• 제목/요약/키워드: drug safety regulation

검색결과 107건 처리시간 0.035초

The G115 standardized ginseng extract: an example for safety, efficacy, and quality of an herbal medicine

  • Bilia, Anna R.;Bergonzi, Maria C.
    • Journal of Ginseng Research
    • /
    • 제44권2호
    • /
    • pp.179-193
    • /
    • 2020
  • Ginseng products on the market show high variability in their composition and overall quality. This becomes a challenge for both consumers and health-care professionals who are in search of high-quality, reliable ginseng products that have a proven safety and efficacy profile. The botanical extract standardization is of crucial importance in this context as it determines the reproducibility of the quality of the product that is essential for the evaluation of effectiveness and safety. This review focuses on the well-characterized and standardized ginseng extract, G115, which represents an excellent example of an herbal drug preparation with constant safety and efficacy within the herbal medicinal products. Over the many decades, extensive preclinical and clinical research has been conducted to evaluate the efficacy and safety of G115. In vitro and in vivo studies of G115 have shown pharmacological effects on physical performance, cognitive function, metabolism, and the immune system. Furthermore, a significant number of G115 clinical studies, most of them double-blind placebo-controlled, have reinforced the findings of preclinical evidence and proved the efficacy of this extract on blood glucose and lipid regulation, chronic obstructive pulmonary disease, energy, physical performance, and immune and cognitive functions. Clinical trials and 50 years of presence on the market are proof of a good safety profile of G115.

Assessment of Biomarkers in Acetaminophen-Induced Hepatic Toxicity by siRNA

  • Kang, Jin-Seok;Yum, Young-Na;Kim, Joo-Hwan;Park, Sue-Nie
    • Biomolecules & Therapeutics
    • /
    • 제17권4호
    • /
    • pp.438-445
    • /
    • 2009
  • We investigated global gene expression from both mouse liver and mouse hepatic cell lines treated with acetaminophen (APAP) in order to compare in vivo and in vitro profiles and to assess the feasibility of the two systems. During our analyses of gene expression profiles, we picked up several down-regulated genes, such as the cytochrome P450 family 51 (Cyp51), sulfotransferase family cytosolic 1C member 2 (Sult1c2), 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1), and several genes that were up-regulated by APAP, such as growth arrest and DNA-damage-inducible 45 alpha (Gadd45a), transformation related protein 53 inducible nuclear protein 1 (Trp53inp1) and zinc finger protein 688 (Zfp688). For validation of gene function, synthesized short interfering RNAs (siRNAs) for these genes were transfected in a mouse hepatic cell line, BNL CL.2, for investigation of cell viability and mRNA expression level. We found that siRNA transfection of these genes induced down-regulation of respective mRNA expression and decreased cell viability. siRNA transfection for Cyp51 and others induced morphological alterations, such as membrane thickening and nuclear condensation. Taken together, siRNA transfection of these six genes decreased cell viability and induced alteration in cellular morphology, along with effective inhibition of respective mRNA, suggesting that these genes could be associated with APAP-induced toxicity. Furthermore, these genes may be used in the investigation of hepatotoxicity, for better understanding of its mechanism.

엑스선골밀도측정기의 기술문서 작성을 위한 가이드라인 개발 연구 (A Study on Development of Guideline on Writing Technical Document for Electrical Medical Devices : Bone Absorptiometric X-ray System)

  • 이승열;김재량;김은림;이준호;이창형;박창원
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제39권2호
    • /
    • pp.263-271
    • /
    • 2016
  • 최근 인구 고령화에 따른 골다공증 환자의 증가 및 의료기기 시장의 성장으로 인해 엑스선골밀도측정기 시장이 커지고 있으며, 이에 따른 의료기기 허가 심사건수가 증가하고 있다. 의료기기 기술문서는 의료기기의 허가 심사 시 가장 기본이 되는 문서로 필수 제출 첨부자료 중 하나이다. 기술문서는 의료기기 관련 법령 및 고시에 그 근거를 두고 있으며, 의료기기 전반적인 항목을 기술해야하는 만큼 작성자의 전문성이 필요한 항목이다. 하지만 최근 부정확한 작성의 증가로 인한 심사자들의 업무부담이 증가되고 있어 민원 처리 효율이 저하되고 있다. 특히 엑스선골밀도측정기의 경우 식품의약품안전처 기준규격이 없어, 의료기기 제조/수입업체 등에서 시험항목을 설정하는 데 많은 어려움을 겪고 있다. 따라서 본 연구에서는 개선된 제도가 반영된, 엑스선골밀도측정기 기술문서 작성 가이드라인 개발을 위해 첫째, 개선된 제도 운영에 대한 조사, 품목별 의료기기의 제도 적용에 따른 문서 작성 방법 검토, 기 허가된 품목에 대한 허가 및 기술문서 검토를 완료하였다. 둘째, 품목별 시장현황 조사, 적용 가능한 국내 외 규격을 조사 분석하여 품목별 국제조화된 안전성 및 성능평가 시험기준 및 방법을 도출하였다. 마지막으로, 산 연 관 전문가협의체 논의를 거쳐 기술문서 작성 가이드라인(안)을 최종 도출하였다.

의료용 표시기의 안전성 및 성능 평가를 위한 시험 항목 및 시험방법(안)연구 (Development of Standards of Tattoo Machine for Safety and Performance Evaluation)

  • 김영균;조승관;이태우;여창민;정병조;권영미;차지훈;허찬희;박기정;김동섭;김한성
    • 대한의용생체공학회:의공학회지
    • /
    • 제32권2호
    • /
    • pp.151-157
    • /
    • 2011
  • Tattooing is a performance for decorative and cosmetic marking by placing permanent ink into the skin. As the cultural meaning of tattoo in Korea is changing, the tattoo machines are widely spread n permanent cosmetic market. Though the use of the tattoo machine was increased, the evaluation standards of tattoo machine were not existed. Korea Food and Drug Association regulated the electrical and mechanical safety standards which were founded on the IEC 601-1 second edition. Also they regulated he biological safety standards which were derived from the ISO 10993 series, however, these general valuations of common medical device were insufficient for evaluating tattoo machine. We developed the standards of tattoo machine for safety and performance evaluation for tattoo machine by preliminary hazard analysis in ISO 14971. The evaluation criteria of tattoo machines are focused on the mechanical invasion. We suggested the additional evaluation items of the needle speed, length, vibration with general valuation criteria of common medical device. We anticipate that this research may be a primary stage to figure a standard regulation and evaluation for tattoo machine.

다지역 임상시험의 계획 및 설계에 대한 국제 제도적 동향 분석 (Regulations and Guidelines for Planning and Design of Multi-regional Clinical Trials)

  • 송윤경;손민지;전아영;김재현;지은희;오정미;김인화
    • 한국임상약학회지
    • /
    • 제28권2호
    • /
    • pp.146-153
    • /
    • 2018
  • Objective: Multi-regional clinical trials have been widely used for accelerating global drug development by multinational pharmaceutical companies. In this study, we aimed to review and analyze the international trends in regulations and guidelines on multi-regional clinical trials by regulatory authorities and international organizations, such as International Conference on Harmonisation, for referring to policies, including development of domestic guidelines for multi-regional clinical trials. Methods: The policies, regulations, and guidelines published by the US Food and Drug Administration, European Medicines Agency, Pharmaceuticals and Medical Devices Agency (Japan), and China Food and Drug Administration were searched, and the International Conference on Harmonisation E17 draft guideline was reviewed. Results: The regulatory authorities in developed countries have developed and implemented regulations and guidelines on multi-regional clinical trials to promote simultaneous global drug development and evaluate the regional differences in drug safety and efficacy. International Conference on Harmonisation developed the draft guideline for planning/designing of multi-regional clinical trials in 2016, which recommends the general principles for strategy-related issues and design of multi-regional clinical trials, and for protocol-related issues, such as consideration of regional variability, subject selection, dose selection, endpoints, comparators, overall sample size, allocation to regions, collecting information on efficacy and safety, and statistical analysis. Conclusion: It is important to understand the international regulatory requirements for designing and planning of multi-regional clinical trials for global drug development. Moreover, it is necessary to prepare multi-regional clinical trial guidelines in accordance with the Korean regulation for clinical trials and drug administration.

COSMOS-standard AISBL과 우리나라 유기농 화장품 기준에 관한 분석 (Comparative Analysis with The COSMOS-standard AISBL and The Regulation of Korean Organic Cosmetic Standard)

  • 최성철;손상목
    • 한국유기농업학회지
    • /
    • 제23권1호
    • /
    • pp.1-18
    • /
    • 2015
  • The purpose of this study is to examine the tendency of certified organic cosmetics market and the certification standards and regulations they are under, compare one of the most commonly used COSMOS-standard AISBL with the Korea Ministry of Food and Drug Safety (MFDS) organic cosmetic standard regulation. And then examining their differences and any potential issues is to present suggestions to be made as data for certification standard for natural & organic cosmetics in Korea regulation. This contents of study will be used as good research and development to promote the sustainable growth of the natural & organic cosmetic ingredients which have been grown by organic farmers certified. Also certified organic ingredients may help to growth the organic industry. I believe these are actual comparative for application to develop of natural and organic cosmetics in Korea as well the strengthening of the competitiveness of organic cosmetics certified in the world.

Gene Expression Profiling in C57BL/6 Mice Treated with the Anorectic Drugs Sibutramine and Phendimetrazine and Their Mechanistic Implications

  • Ko, Moon-Jeong;Choi, Hyo-Sung;Ahn, Joon-Ik;Kim, So-Young;Jeong, Ho-Sang;Chung, Hye-Joo
    • Genomics & Informatics
    • /
    • 제6권3호
    • /
    • pp.117-125
    • /
    • 2008
  • Recently, obesity has become a worldwide public health concern and the use of anorectic drugs has drastically increased. In this study, sibutramine and phendimetrazine, representative marketed anorectics, were repeatedly administered per os on a daily basis into C57BL/6 mice and the effects of these drugs on food intakes, body weight changes and gene expression profiles were monitored for up to following 7 days. Methamphetamine, which has a potent anorectic effect, was used as a positive control. Anorectic effects were sustained only for two days by phendimetrazine or methamphetamine, but for six days by sibutramine. The modulations of gene expressions in the hypothalamus and the striatum were investigated using microarrays on day 2 and day 7 post-administration, which corresponded to the anorectic period and a return of appetite respectively, for all three drugs tested. Differences in overall gene expression profiles in the stratum on day 2 for sibutramine and phendimetrazine seems to reflect difference between the two in terms of the onsets of drug tolerance. According to microarray findings, the Ankrd26 gene appears to have an important anorectic role, whereas the up-regulation of the olfaction system appeared to be involved in the drug tolerance of anorectics. The microarray data presented in this study demonstrates the usefulness of gene expression analysis for gathering information on the efficacy and safety of anorectic drugs.

레토르트 파우치 포장재의 사용조건에 따른 이행물질의 조사 (Studies on the Substance of Migration for Retort Pouch Packaging Materials for Various Condition)

  • 이만술;송범호;박선오;이부영;이영자;윤혜경;엄미옥;성준형;전대훈
    • 한국포장학회지
    • /
    • 제13권3_4호
    • /
    • pp.107-112
    • /
    • 2007
  • 시중에서 유통되고 있는 레토르트 및 전자렌지용 식품을 조사하여 이들 식품에 주로 사용하고 있는 포장재에 대하여 가혹한 조건을 설정하여 용출시험을 수행하였다. 시중에서 판매되고 있는 레토르트 및 전자렌지용 식품 186품목은 모두 그 구성이 PET, 알루미늄, 나일론, 에틸렌 비닐알콜 및 폴리프로필렌 등5개 품목으로 구성되어 있으며 식품과 접촉하는 면은 모두 폴리프로필렌으로 되어 있었다. 재질에 따른 이행물질을 검사하기 위하여 가장 널리 사용되고 있는 레토르트용 포장재 6종, 전자렌지용 포장재 11종에 대한 용출시험항목인 과망간산칼륨소비량, 이소시아네이트 및 카프로락탐을 검사하였다. 용출용매는 물, 4%초산, 20%알콜 그리고 n-헵탄을 사용하였으며 레토르트용 포장재의 경우 $25^{\circ}C{\times}30$분, $60^{\circ}C{\times}30$분, $95^{\circ}C{\times}30$분, $100^{\circ}C{\times}2$시간의 온도와 시간을 사용하였다. 전자렌지용 포장재의 경우 그 사용조건을 고려하여 2분, 4분을 가열시간으로 하였다. 본 연구의 결과 과망간산칼륨소비량의 경우 식품공전에 의한 기준을 초과한 것은 하나도 없으며 이소시아네이트, 카프로락탐에서도 가혹한 용출조건임에도 불구하고 그 결과는 모두 불검출로 나타났다. 이러한 결과를 고려하면 현재의 규격은 내열성 플라스틱 용기에 대한 충분한 안전관리가 이루어질 수 있다는 것을 알 수 있다. 다만, 새로운 위해요소로 떠오를 수 있는 물질에 대한 관심은 지속적으로 이루어져야 할 것으로 판단된다.

  • PDF

시판 후 의료기기 임상평가를 위한 체계적 문헌고찰 활용 방안 연구: 안과용전기수술기 사례를 중심으로 (A Study on the Application of Systematic Literature Review for Post-Market Clinical Evaluation of Medical Devices: Focused on the Ophthalmic Electrosurgical system)

  • 김병관;최영숙;김미선;양석조
    • 대한의용생체공학회:의공학회지
    • /
    • 제41권1호
    • /
    • pp.35-41
    • /
    • 2020
  • In this study, we examined whether the systematic literature review method used in the field of evidence-based medicine could be used for post-market clinical evaluation of medical devices by modifying them to fit the regulatory perspective of medical devices in Korea. For this purpose, systematic literature review was modified and applied to conduct a clinical literature survey on the ophthalmic electrosurgical system(Trabectome®, NeoMediX Corp) used for the treatment of glaucoma. A total of six documents were finally selected, and clinical safety and efficacy information on the indications of the ophthalmic electrosurgical system were effectively presented. In addition, general safety information and unexpected safety information could be distinguished through comparison with medical device adverse event reporting cases. The method used in this study is expected to be used in various ways throughout post-market medical device safety management system and for the purpose of regulation improvement, especially in the field of ophthalmic electrosurgical system.

Good Laboratory Practice Requirements in Oriental Pharmacy

  • Seo, Min-Jun;Lee, Jae-Jun;Park, Jin-Han
    • Journal of Evidence-Based Herbal Medicine
    • /
    • 제1권1호
    • /
    • pp.29-34
    • /
    • 2008
  • Good Laboratory Practice(GLP) is becoming more and more important in the research and development of Oriental Pharmacy(OP) and its globalization. If a OP product is to be registered as Over-the-Counter(OTC) drug and enter international markets, the safety and efficacy studies conducted according to GLP requirements is necessary. The article introduces the content of GLP requirements and the recent development of GLP. The safety and efficacy assessment for OP or herbal medicines under GLP are also covered. This paper also briefly describes the areas that should be covered by GLP regulation and the areas that do not need to follow GLP requirements.

  • PDF